Vincerx Pharma, Inc. (VINC)

CIK 1796129 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Vincerx Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Jul 29, 2025SCHEDULE 13G/A0001085146-25-004280
Jul 16, 2025DEFA14A0001193125-25-159868
Jul 7, 20258-K0001193125-25-156210
Jul 7, 2025DEFA14A0001193125-25-156217
Jun 18, 2025DEFA14A0001193125-25-142729
Jun 18, 2025DEFA14A0001193125-25-142729
Jun 6, 2025DEFA14A0001193125-25-137028
May 15, 2025SCHEDULE 13G/A0001172661-25-002218
May 15, 202510-Q0001193125-25-120762
May 12, 2025DEF 14A0001193125-25-117863
May 2, 2025EFFECT9999999995-25-001378
May 2, 2025EFFECT9999999995-25-001386
May 2, 2025EFFECT9999999995-25-001377
May 1, 2025S-8 POS0001193125-25-110105
May 1, 2025S-8 POS0001193125-25-110102
May 1, 2025S-8 POS0001193125-25-110103
May 1, 2025POS AM0001193125-25-110095
May 1, 2025POS AM0001193125-25-110098
May 1, 2025POS AM0001193125-25-110092
May 1, 2025S-8 POS0001193125-25-110107
May 1, 2025S-8 POS0001193125-25-110100
Apr 30, 2025PRE 14A0001193125-25-107499
Apr 28, 2025250001193125-25-100448
Apr 17, 20258-K0001193125-25-084406
Apr 11, 20258-K0001193125-25-079090